AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ISLAND PHARMACEUTICALS LTD

0.440

0.000

Volume:42.22K

Turnover:18.12K

Market Cap:129.70M

PE:-12.09

High:0.440

Open:0.430

Low:0.425

Close:0.440

52wk High:0.630

52wk Low:0.200

Shares:294.77M

Float Shares:110.76M

Volume Ratio:1.51

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.036

EPS(LYR):-0.036

ROE:-95.50%

ROA:-60.12%

PB:9.64

PE(LYR):-12.09

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Island Pharmaceuticals Says Pivotal Marburg Data Secured for Galidesivir FDA Pathway

Island Pharmaceuticals Gets Approval to Cross-Reference Non-Human Primate Study in Marburg-Angola Virus Regulatory Submissions

MT Newswires Live

Island Pharmaceuticals - Receives Loa to Cross-Reference Marburg-Angola Nhp Data in FDA Submissions

THOMSON REUTERS

Island Pharmaceuticals Posts Prelim FY Loss Attributable of A$9.8 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/ILA.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ILA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ILA.AU\",,,,,undefined,":{"symbol":"ILA.AU","market":"AU","secType":"STK","nameCN":"ISLAND PHARMACEUTICALS LTD","latestPrice":0.44,"timestamp":1788225878542,"preClose":0.44,"halted":0,"volume":42223,"delay":0,"changeRate":0,"nameEN":"ISLAND PHARMACEUTICALS LTD","floatShares":110756995,"shares":294766682,"eps":-0.0364,"marketStatus":"Trading","change":0,"latestTime":"09-01 11:33:57 AEST","open":0.43,"high":0.44,"low":0.425,"amount":18124,"amplitude":0.034091,"askPrice":0.435,"askSize":1432,"bidPrice":0.425,"bidSize":1264,"shortable":3,"etf":0,"ttmEps":-0.0364,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788242400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.44,"openAndCloseTimeList":[[1788220800000,1788242400000]],"volumeRatio":1.50541,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ILA.AU","preClose":0.44,"auctionPrice":0.43,"auctionVolume":1388,"auctionTime":1788220762102,"referenceTime":1788172203092,"auction":1,"marketStatus":"盘前竞价","timestamp":1788220762102}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ILA.AU\",,,,,undefined,":{"symbol":"ILA.AU","floatShares":110756995,"roa":"-60.12%","roe":"-95.50%","lyrEps":-0.0364,"volumeRatio":1.50541,"shares":294766682,"dividePrice":0,"high":0.44,"amplitude":0.034091,"preClose":0.44,"low":0.425,"week52Low":0.2,"pbRate":"9.64","psRate":"458.85","week52High":0.63,"institutionHeld":0,"latestPrice":0.44,"committee":-0.062315,"eps":-0.0364,"divideRate":0,"volume":42223,"delay":0,"ttmEps":-0.0364,"open":0.43,"prevYearClose":0.43,"prevWeekClose":0.44,"prevMonthClose":0.44,"prevQuarterClose":0.38,"fiveDayClose":0.465,"twentyDayClose":0.415,"sixtyDayClose":0.35,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ILA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ILA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ILA.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663049025","title":"Island Pharmaceuticals Says Pivotal Marburg Data Secured for Galidesivir FDA Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2663049025","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663049025?lang=en_us&edition=fundamental","pubTime":"2026-08-31 09:51","pubTimestamp":1788141090,"startTime":"0","endTime":"0","summary":"BRIEF-Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA PathwayAug 31 -Island Pharmaceuticals LtdILA.AX:PIVOTAL MARBURG DATA SECURED FOR GALIDESIVIR FDA PATHWAYRECEIVES LOA TO CROSS-REFERENCE MARBURG-ANGOLA NHP DATA IN FDA SUBMISSIONSFurther company coverage:ILA.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE5PYMHC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663641023","title":"Island Pharmaceuticals Gets Approval to Cross-Reference Non-Human Primate Study in Marburg-Angola Virus Regulatory Submissions","url":"https://stock-news.laohu8.com/highlight/detail?id=2663641023","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663641023?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:54","pubTimestamp":1788137649,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  received authorization to cross-reference a detailed non-human primate natural history study of Marburg-Angola virus in submissions to the US Food and Drug Administration , according to a Monday filing with the Australian bourse.The letter of authorization follows more than six months of negotiations to secure access to the original natural history study, and addresses an information requirement identified by the US FDA, per the filing.Island Pharmaceuticals is advancing galidesivir as a potential medical countermeasure for Marburg virus disease under the FDA's animal rule, which provides a pathway for approval in cases where human efficacy trials are unethical or infeasible.The company said the authorization will provide savings in development time and capital as it will not have to independently recreate an equivalent Marburg natural history program.Marburg virus disease is an often fatal viral illness that causes bleeding inside and outside the body, accordin","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663904098","title":"Island Pharmaceuticals - Receives Loa to Cross-Reference Marburg-Angola Nhp Data in FDA Submissions","url":"https://stock-news.laohu8.com/highlight/detail?id=2663904098","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663904098?lang=en_us&edition=fundamental","pubTime":"2026-08-31 07:02","pubTimestamp":1788130925,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nTUE5PYMHC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662750762","title":"Island Pharmaceuticals Posts Prelim FY Loss Attributable of A$9.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662750762","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662750762?lang=en_us&edition=fundamental","pubTime":"2026-08-26 13:08","pubTimestamp":1787720895,"startTime":"0","endTime":"0","summary":"BRIEF-Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 MillionAug 26 -Island Pharmaceuticals LtdILA.AX:NO DIVIDENDS PAID, RECOMMENDED OR DECLARED DURING CURRENT FINANCIAL PERIODFY PRELIM INCOME FROM ORDINARY ACTIVITIES UP 214.6% TO A$559,080PRELIM FY LOSS ATTRIBUTABLE OF A$9.8 MILLIONFurther company coverage:ILA.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nTUE7GFNJS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ILA.AU\",params:#limit:6,delay:true,,,undefined,":[]}}